Navigation Links
23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire
Date:6/25/2013

lope, Chef de l'Unité Hypertension à l'Hôpital du 12 Octobre de Madrid en Espagne, et investigateur principal de l'étude SEVITENSION. "Les études post-commercialisation telles que celle-ci fournissent des données importantes pour aider les médecins à choisir les meilleures options thérapeutiques afin de prendre en charge de manière plus efficace et plus pratique l'hypertension artérielle, et ainsi de mieux protéger les patients. Cette amélioration potentielle dans la prise en charge de l'HTA aidera les médecins à atteindre l'objectif ambitieux de contrôler la pression artérielle chez au moins 70% des patients hypertendus d'ici 2015."

Les médicaments tels que les inhibiteurs de l'enzyme de conversion de l'angiotensine (IEC) réduisent la pression artérielle en inhibant l'activité du système rénine-angiotensine (SRA). Une classe plus récente de médicaments antihypertenseurs, appelés antagonistes du récepteur de l'angiotensine (ARA II) réduit aussi la pression artérielle en inhibant le SRA, et offre l'avantage de provoquer moins d'effets secondaires que les IEC, notamment la toux.[7]

Daiichi Sankyo soutient activement la recherche sur les antihypertenseurs, et a développé toute une gamme de médicaments à base de l'ARA II olmésartan. Un de ces produits, l'association fixe olmésartan/amlodipine (Sevikar®), a été utilisée pour tenter de répondre à une question clinique importante : est-ce que l'association de deux médicaments composée d'un ARA II tel que l'olmésartan, et de l'amlodipine peut réduire la pression artérielle centrale aussi efficacement que l'association du périndopril et de l'amlodipine ? Cette question a &#
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
3. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. ETEX Corporation to present at the 9th World Biomaterial Congress
8. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
9. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
10. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
11. BIOCOM Announces Endorsement in 52nd Congressional District Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Rock Hill, SC (PRWEB) October 22, 2014 ... the expansion of its cardiovascular pharmacogenetics menu, which ... improved patient outcomes. With PCLS’s evidence-based results, ... individual needs and optimize their therapy, while minimizing ... , In the U.S., according to the FDA ...
(Date:10/22/2014)... 22, 2014 Nuvilex, Inc. (OTCQB: NVLX) – ... people worldwide are living with diabetes, with  that number ... The global market for diabetes treatments is approximately $500 ... worldwide died from pancreatic cancer.  Pancreatic cancer is the ... in the United States , and ...
(Date:10/20/2014)... Mapp Biopharmaceutical,s valiant effort to produce ... fight the Ebola outbreak will make the public ... of pharmaceuticals can be, according to Kalorama Information.  ... some may be taken aback by the three-month ... knowledge are well aware of the complex issues ...
(Date:10/20/2014)... , October 20, 2014 , ... (GI) disorders and the delivery of care has revealed ... and worrying inequalities in the provision of healthcare services ... was commissioned by United European Gastroenterology (UEG), have been ... and public awareness of the burden of GI disorders ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5
... 31 CryoLife, Inc. (NYSE: CRY ),a biomaterials, ... quarter and year end 2007 financial results will be,released ... a,teleconference call and live webcast at 10:00 a.m. Eastern ... a question and answer session,hosted by Steven G. Anderson, ...
... and clinicians identify best ... heart disease, BIRMINGHAM, Ala., Jan. 31 Clinical ... the need for more,detailed cholesterol testing, including direct measurement ... cardio-diagnostic company that,has developed an expanded cholesterol test called ...
... Reported Diluted Earnings per Share Increased 19% to $0.75. Diluted, Earnings per Share, ... ... Net Revenue Increased 10% to $22.4 Billion and Reported Diluted Earnings per Share Increased ... to ...
Cached Biology Technology:CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 3Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 2Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 3Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 4Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 5Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 6Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 7Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 8Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 9Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 10Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 11Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 12Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 13Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 14Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 15
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... our ability to assess the pandemic risk from strains ... we must not allow ourselves to become complacent that ... international consortium of scientists. , Influenza pandemics arise when ... yet to develop widespread immunity – spreads in the ... the past 100 years, the worst of which – ...
(Date:10/15/2014)... 15, 2014 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market releases photos and video of ... on Monday October 13 th . Gino ... and angel investor Mr. Chad A. Verdi rang ... NXT-ID thanked his investors and employees "for their work and dedication ...
Breaking Biology News(10 mins):Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3
... landmark Cleveland institutions have come together to launch a ... sclerosis (MS). Researchers at the Cleveland Clinic, University Hospitals ... on a ground-breaking study that will test the feasibility ... to treat MS. In patients with MS, the ...
... Visualization" award in the "commercial" category of Illumina,s Data ... proud of. iDEA is Illumina,s program designed to challenge ... and data analysis techniques. "The iDEA challenge really ... heard about it. Genomatix is a scientific company at ...
... Tampa, FL (August 23, 2011) -- The first international ... of Pharmacy will focus on ways to improve health ... an individual,s genetic makeup. The 1st Annual International ... held Sept. 22 to 24 at the Dr. Kiran ...
Cached Biology News:Cleveland researchers collaborate to launch Phase 1 clinical trial for new MS treatment 2Cleveland researchers collaborate to launch Phase 1 clinical trial for new MS treatment 3Cleveland researchers collaborate to launch Phase 1 clinical trial for new MS treatment 4Cleveland researchers collaborate to launch Phase 1 clinical trial for new MS treatment 5International pharmacogenomics conference to focus on better drug treatment based on genetics 2
...
... This CLS number is a ... match Cornings product number. If showing ... the old Sigma-Aldrich number (R4276) or ... Material: cap polystyrene (expanded surface, easy ...
... Custom Peptide Services offer a full range ... research needs. Services include: Peptide synthesis, ... Peptide synthesis, purified product (70-95% pure) ... amidation, biotinylation, fluorescein, myristylation, phosphorylation, and rhodamine) ...
... ELISPOT (enzyme-lined immunospot) Kit analyzes interferon gamma ... A spot forms at the site where ... using a dissection microscope or automated ELISPOT ... of cells added to the microplate. This ...
Biology Products: